Remdesivir under study as treatment for novel coronavirus

MDedge ^ | 2/7/2020 | Doug Brunk

[gandalftb]

There are two basic issues that control lethality.
...........
1. Susceptibility, how available are certain people to this virus?
...........
2. Impairment, when people get sick, how good are their bodies at getting better?
...............
Everyone though, can get sick.
............
Although the sample size is very small for now, researchers have noticed that certain kinds of lung cells are “gateways” for the virus.
...........
Those small minority (about 3%) of lung cells are 3-4 times more prevalent in Asian males than they are in Asian females or male/female whites and blacks. There may be a linkage to blood pressure meds also.
...........
Pack those Asian males together, with some of them being very mobile, bingo, epidemic and possible pandemic.
............
Impairment of self-healing is an issue. Smoking doesn’t appear to be a major factor. Age is, and heart/lung background problems are present in nearly all deaths.
..............
The virus is easily killed outside the host, particularly by air temperature or antiseptic chemicals. Summer is coming. Fumigation is happening.
................
Once the available population is either healed or dead, the virus will disappear. Although it is showing a remarkable ability to mutate.

[DoughtyOne]

It was used on the first U. S. Case in Washington state.

It cured the patient in short order.

They had tried other things and they weren’t working.

https://www.nejm.org/doi/full/10.1056/NEJMoa2001191